The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
Open accessAbstract
Christopher A. Ross Laboratory of Molecular Neurobiology Departments of Psychiatry and Neuroscience Program in Cellular and Molecular Medicine Johns Hopkins Medical School Baltimore, Maryland 21205 Five neurodegenerative diseases are caused by ex- panding CAG triplet repeats coding for polyglutamine. They all involve loss of selected populations of neurons, usually in adulthood. How the genetic lesions cause pro- gressive neuronal degeneration is unknown. Unraveling the pathogenesis of these disorders will help elucidate pathways of neuronal cell death. Triplet repeat disorders involve the recently identified phenomenon of unstable DNA, in which repeating units of 3 nucleotides such as CAG expand during vertical trans- mission and cause disease (La Spada et al., 1994). They can be divided into two types. The first type (Figure 1) involves expanding CAG repeats coding for polygluta- mine. The normal length of the repeat is from 6 or 7 to about 30, and the disease is present when the repeat expands to 35-40 or more. Except for the androgen receptor of spinal and bulbar muscular atrophy (SBMA), none of the caus- ative genes has a known function or substantial homology with any known gene in the database. In the second type of disease (Table 1), triplet repeats such as CTG or CCG are present in mRNA outside the open reading frame (La Spada et al., 1994; Ross et al., 1993). In all of the glutamine repeat diseases, there is loss of neurons with gliosis, but without deposition of extracellular material or intracellular inclusion bodies. Though the ex- pression patterns of the causative genes are widespread, the disorders involve loss of neurons within specific re- gions of the brain and spinal cord (Figure 1). It is possible that the glutamine repeat diseases share similar mecha- nisms of pathogenesis. Glutamine Repeat Diseases and Causative Genes Huntington's disease (HD) is the most common glutamine repeat disease. It is an autosomal dominant neurodegen- erative disorder characterized by abnormal movements including chorea, dementia, and emotional disorders. The pathology is notable for selective neuronal vulnerability of medium spiny projection neurons in the caudate and putamen. After a long search, the HD gene was identified and found to have an expanding CAG repeat (Huntington's Disease Collaborative Research Group, 1993). The mRNA contains a long open reading frame coding for a predicted protein of 348 kDa. Immediately adjacent to the glutamine repeat, there are two proline repeats interrupted by a pro- line-rich region. The protein product of the HD gene (hun- tingtin), like the mRNA, has a widespread expression in both the brain and the periphery (Sharp et al., 1995; Trot- tier et al., 1995). Within the brain, it is predominantly neu- ronal with no enrichment in the basal ganglia. It is present in cell bodies and dendrites and appears enriched in neu- ronal terminals, possibly associated with vessicles or mi- crotubules (DiFiglia et al., 1995; Gutekunst et al., 1995). Dentato-Rubral and Pallido-Luysian Atrophy (DRPLA or Smith's Disease) is a rare neurodegenerative disorder whose clinical features for adult onset cases are similar to those of HD. DRPLA was the first triplet repeat disease- causing gene
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. R. L., Wilson, E. M., Lubahn, D. B., Harding, A. E., & Fischbeck, K. H. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,784
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 961
Nasir, J., Floresco, S. B., O'Kusky, J. R., Diewert, V. M., Richman, J. M., Zeisler, J., Borowski, A., Marth, J. D., Phillips, A. G., & Hayden, M. R. (1995) · Cell · doi:10.1016/0092-8674(95)90542-1 · Cited by 872
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
DiFiglia, M., Sapp, E., Chase, K., Schwarz, C., Meloni, A., Young, C., Martin, E., Vonsattel, J.-P., Carraway, R., Reeves, S. A., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90346-1 · Cited by 749 · cited 1×
“It is present in cell bodies and dendrites and appears enriched in neuronal terminals, possibly associated with vessicles or microtubules (DiFiglia et al., 1995; Gutekunst et al., 1995).”
BackgroundInactivation of the Mouse Huntington's Disease Gene Homolog Hdh
Duyao, M. P., Auerbach, A. B., Ryan, A., Persichetti, F., Barnes, G. T., McNeil, S. M., Ge, P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., et al. (1995) · Science · doi:10.1126/science.7618107 · Cited by 723
SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat
Burright, E. N., Brent Clark, H., Servadio, A., Matilla, T., Feddersen, R. M., Yunis, W. S., Duvick, L. A., Zoghbi, H. Y., & Orr, H. T. (1995) · Cell · doi:10.1016/0092-8674(95)90273-2 · Cited by 595
Alternative excitotoxic hypotheses
Albin, R. L., & Greenamyre, J. T. (1992) · Neurology · doi:10.1212/wnl.42.4.733 · Cited by 574 · cited 1×
“An elaboration on this model suggests that metabolically compromised neurons might be more sensitive to excitotoxicity or other forms of toxicity (Albin and Greenamyre, 1992; Beal, 1992).”
Background
Cited by
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Self-citationDavies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Self-citationScherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291
Nucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V. L., et al. (2001) · Science · doi:10.1126/science.1056784 · Cited by 1,094
Self-citationClinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A., & Koenig, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351601 · Cited by 1,071
Metadata
- Authors
- Ross, C. A.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1995-09
- Volume
- 15
- Issue
- 3
- Pages
- 493-496
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2069850109
- Cited by
- 260
- References
- 26
- FWCI
- 11.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. https://app.cochat.ai/papers/10.1016/0896-6273(95)90138-8
- The paper
- Ross, C. A. (1995). When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases. Neuron. https://doi.org/10.1016/0896-6273(95)90138-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.